SCHEMBL7659419

SCHEMBL7659419

CCCCC(NC(=O)c1ccccc1-c1ccccc1)C(=O)CNC(=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.44
CLPP Q16740 2/20 0.43
CHRNB2 P17787 1/20 0.43
CHRNB4 P30926 1/20 0.43
CHRNA3 P32297 1/20 0.43
CHRNA4 P43681 1/20 0.43
KCNA5 P22460 1/20 0.42
CAPN1 P07384 3/20 0.41
CA2 P00918 1/20 0.41
PRSS1 P07477 1/20 0.41
CTSG P08311 1/20 0.41
CTRB1 P17538 1/20 0.41
CMA1 P23946 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
FOLH1 Q04609 1/20 0.41
NPFFR1 Q9GZQ6 1/20 0.41
NPFFR2 Q9Y5X5 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7657278 0.90 CLPP (0.44) CLPPCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7666903 0.84 KDM4E (0.47) NAAAPRSS1CTSGCTRB1CMA1
SCHEMBL7428183 0.83 LTB4R2 (0.44) CLPPCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7689953 0.82 CHRNB2 (0.52) CHRNB2CHRNB4CHRNA3CHRNA4CAPN1
SCHEMBL7694185 0.82 CAPN1 (0.56) NAAACAPN1CA2PRSS1CTSG
SCHEMBL7428250 0.81 KCNA5 (0.44) CLPPKCNA5CAPN1CA2MEN1
SCHEMBL7393060 0.78 NAAA (0.48) NAAACLPPCHRNB2CHRNB4CHRNA3
SCHEMBL7693965 0.78 CAPN1 (0.46) NAAACAPN1MEN1KMT2ANPC1
SCHEMBL7697322 0.77 CAPN1 (0.54) CAPN1TACR3
SCHEMBL7693912 0.75 CAPN1 (0.73) CAPN1KMT2AMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed